Lightlake Therapeutics Inc. - Product Pipeline Review - 2013

Market: Pharmaceuticals and Healthcare

Global, 24 pages report, published by Global Markets Direct

Keywords : Current R&D Portfolio of Lightlake Therapeutics Inc.; Lightlake Therapeutics Inc. - Key Therapeutics; Lightlake Therapeutics Inc. - Pipeline Overview and Promising Molecules; Lightlake Therapeutics Inc. - News; Lightlake Therapeutics Inc. - Latest Updates; Lightlake Therapeutics Inc. - Pipeline; Lightlake Therapeutics Inc. - Discontinued/Dormant Projects

Report ThumbnailAugust-2013
Lightlake Therapeutics Inc. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Lightlake Therapeutics Inc. - Product Pipeline Review - 2013” provides data on the Lightlake Therapeutics Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Lightlake Therapeutics Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Lightlake Therapeutics Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Lightlake Therapeutics Inc. - Brief Lightlake Therapeutics Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Lightlake Therapeutics Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Lightlake Therapeutics Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Lightlake Therapeutics Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Lightlake Therapeutics Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Lightlake Therapeutics Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Lightlake Therapeutics Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Lightlake Therapeutics Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Lightlake Therapeutics Inc. and identify potential opportunities in those areas.
  • List of Figures
  • Lightlake Therapeutics Inc. - Pipeline by Indication, 2013 6
  • Lightlake Therapeutics Inc. - Pipeline by Stage of Development, 2013 7
  • Lightlake Therapeutics Inc. - Monotherapy Products in Pipeline, 2013 8
  • Lightlake Therapeutics Inc. - Pipeline By Therapeutic Class, 2013 15
  • Lightlake Therapeutics Inc. - Pipeline Products By Mechanism of Action, 2013 18
  • List of Tables
  • Lightlake Therapeutics Inc., Key Information 4
  • Lightlake Therapeutics Inc., Key Facts 4
  • Lightlake Therapeutics Inc. - Pipeline by Indication, 2013 6
  • Lightlake Therapeutics Inc. - Pipeline by Stage of Development, 2013 7
  • Lightlake Therapeutics Inc. - Monotherapy Products in Pipeline, 2013 8
  • Lightlake Therapeutics Inc. - Phase II, 2013 9
  • Lightlake Therapeutics Inc. - Phase I, 2013 10
  • Lightlake Therapeutics Inc. - Pipeline By Therapeutic Class, 2013 15
  • Lightlake Therapeutics Inc. - Pipeline By Target, 2013 16
  • Lightlake Therapeutics Inc. - Pipeline By Route of Administration, 2013 17
  • Lightlake Therapeutics Inc. - Pipeline Products By Mechanism of Action, 2013 18
  • Lightlake Therapeutics Inc. - Recent Pipeline Updates, 2013 19
  • Table of Contents
  • Table of Contents 2
  • List of Tables 3
  • List of Figures 3
  • Lightlake Therapeutics Inc. Snapshot 4
  • Lightlake Therapeutics Inc. Overview 4
  • Key Information 4
  • Key Facts 4
  • Lightlake Therapeutics Inc. - Research and Development Overview 5
  • Key Therapeutic Areas 5
  • Lightlake Therapeutics Inc. - Pipeline Review 7
  • Pipeline Products by Stage of Development 7
  • Pipeline Products - Monotherapy 8
  • Lightlake Therapeutics Inc. - Pipeline Products Glance 9
  • Lightlake Therapeutics Inc. Clinical Stage Pipeline Products 9
  • Phase II Products/Combination Treatment Modalities 9
  • Phase I Products/Combination Treatment Modalities 10
  • Lightlake Therapeutics Inc. - Drug Profiles 11
  • LT-12 11
  • Product Description 11
  • Mechanism of Action 11
  • R&D Progress 11
  • LT-20 12
  • Product Description 12
  • Mechanism of Action 12
  • R&D Progress 12
  • LT-21 13
  • Product Description 13
  • Mechanism of Action 13
  • R&D Progress 13
  • LT-22 14
  • Product Description 14
  • Mechanism of Action 14
  • R&D Progress 14
  • Lightlake Therapeutics Inc. - Pipeline Analysis 15
  • Lightlake Therapeutics Inc. - Pipeline Products by Therapeutic Class 15
  • Lightlake Therapeutics Inc. - Pipeline Products By Target 16
  • Lightlake Therapeutics Inc. - Pipeline Products by Route of Administration 17
  • Lightlake Therapeutics Inc. - Pipeline Products By Mechanism of Action 18
  • Lightlake Therapeutics Inc. - Recent Pipeline Updates 19
  • Lightlake Therapeutics Inc. - Company Statement 21
  • Lightlake Therapeutics Inc. - Locations And Subsidiaries 22
  • Head Office 22
  • Appendix 23
  • Methodology 23
  • Coverage 23
  • Secondary Research 23
  • Primary Research 23
  • Expert Panel Validation 23
  • Contact Us 24
  • Disclaimer 24

Please select a license type

Share

Related Products

Global Markets DirectLightlake Therapeutics Inc. - Product Pipeline Review - 2013Product ThumbnailLightlake Therapeutics Inc. - Product Pipeline Review - 2013, Industry ReportProduct #: 110769
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved